Novo Nordisk (NVO) is down -20.4%, or -$14.10 to $54.90.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk Stock (NVO) Plunges 20% on Guidance Cut and CEO Appointment
- Video: Boeing results, dealmaking highlight busy morning
- Novo Nordisk Lowers 2025 Sales and Profit Outlook Amid Market Challenges
- Novo Nordisk Appoints New CEO Amid Strategic Restructuring
- Novo Nordisk appoints Maziar Mike Doustdar as CEO